The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: anemia, biomarkers, and recent therapeutic trial implications.
Abstract |
|
Authors | Gordon W Moe, Justin A Ezekowitz, Eileen O'Meara, Serge Lepage, Jonathan G Howlett, Steve Fremes, Abdul Al-Hesayen, George A Heckman, Howard Abrams, Anique Ducharme, Estrellita Estrella-Holder, Adam Grzeslo, Karen Harkness, Sheri L Koshman, Michael McDonald, Robert McKelvie, Miroslaw Rajda, Vivek Rao, Elizabeth Swiggum, Sean Virani, Shelley Zieroth, J Malcolm O Arnold, Tom Ashton, Michel D'Astous, Michael Chan, Sabe De, Paul Dorian, Nadia Giannetti, Haissam Haddad, Debra L Isaac, Simon Kouz, Marie-Hélène Leblanc, Peter Liu, Heather J Ross, Bruce Sussex, Michel White, Canadian Cardiovascular Society |
Journal | The Canadian journal of cardiology
(Can J Cardiol)
Vol. 31
Issue 1
Pg. 3-16
(Jan 2015)
ISSN: 1916-7075 [Electronic] England |
PMID | 25532421
(Publication Type: Journal Article, Practice Guideline)
|
Copyright | Copyright © 2015 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Angiotensin Receptor Antagonists
- Biomarkers
- Mineralocorticoid Receptor Antagonists
- Neprilysin
|
Topics |
- Anemia
(blood, prevention & control)
- Angiotensin Receptor Antagonists
(therapeutic use)
- Biomarkers
(blood)
- Blood Pressure
- Canada
- Cardiology
(organization & administration)
- Clinical Trials as Topic
- Heart Failure
(blood, diagnosis, drug therapy)
- Humans
- Mineralocorticoid Receptor Antagonists
(therapeutic use)
- Neprilysin
(antagonists & inhibitors)
- Societies, Medical
(organization & administration)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|